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Background: Zhuyeqing Liquor (ZYQL), a well-known Chinese traditional health liquor, has various biological
properties, including anti-oxidant, anti-inflammatory, immunoenhancement and cardiovascular protective effects.
Methods: The protective effects of Zhuyeqing Liquor (ZYQL) on the immune function was investigated in vivo in
normal healthy mice and immunosuppressed mice treated with Cyclophosphamide (Cy, 100 mg/kg) by
intraperitoneal injection on days 4, 8 and 12. ZYQL (100, 200 and 400 mg/kg) was administered via gavage daily for
14 days. The phagocytotic function of mononuclear phagocytic system was detected with carbon clearance
methods, the levels of interleukin-6 (IL-6) and interferon-gamma (IFN-γ) in serum were detected with Enzyme linked
immunosorbent assay (ELISA). Immune organs were weighed and organ indexes (organ weight/body weight) of
thymus and spleen were calculated. Meanwhile, the activity of lysozyme (LSZ) in serum and the activity of
superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) in spleen tissue were measured.
Results: ZYQL significantly upgrades the K value for clearance of carbon particles in normal mice treated with ZYQL
(400 mg/kg) and immunosuppressed mice treated with ZYQL (100, 200 and 400 mg/kg) together with Cy (100 mg/
kg) in vivo. The treatment of ZYQL (100, 200 and 400 mg/kg) effectively increased the activity of serum lysozyme as
well as promoted the serum levels of IL-6 and IFN-γ in normal mice and immunosuppressed mice. Furthermore,
ZYQL (100, 200 and 400 mg/kg) had an antioxidant effects in immune system by enhancing the antioxidant
enzyme activity of SOD, CAT and GSH-Px in vivo. In addition, ZYQL (100, 200 and 400 mg/kg) effectively elevated
the Cy-induced decreased organ index (thymus and spleen).
Conclusions: The present work shows that the dose-dependent administration of ZYQL is capable of influencing
immune responses, which implying that its valuable functional health may be attributed partly to its protective
effects for the immune function.
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Zhuyeqing Liquor (ZYQL), a well-known Chinese trad-
itional health liquor, has been formally authorized as a
functional health liquor in 1998 by Ministry of Public
Health in China. It is sold commercially and is a com-
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reproduction in any medium, provided the orlong time history use of ZYQL has been proved that
drinking ZYQL could keep body health and anti-fatigue.
And with the improvement of the technology, especially
with the applications of modern analytical tools and test
equipment, its special composition as well as nutrition
and health functions were further recognized. Through
scientific experimental verification, its effectiveness of
health care towards stomach, spleen and liver etc., is
gradually disclosed and recognized by consumers [1].
Health food constituents possess not only nutritional
value but can also have physiological effects by modulating. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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substances for enhancing host defense responses were
isolated from microorganisms, fungi and plants [2-4].
And some herbal medicines have been frequently used
as tonic medicines to add into some special functional
food in order to treat or protect from several diseases
such as autoimmune diseases, inflammations and aller-
gies, which are difficult to Western medicines. Moreover,
plant-derived polysaccharides are the best known and
most potent immunomodulatory substances and have
been shown to be clinically therapeutic [5]. And their
chemical properties and biological activities have been stud-
ied extensively. In the present study, ZYQL consists of
twelve crude drugs: Lophatherum gracile Brongn.
(Gramineae), Gardenia jasminoides Ellis (Rubiaceae),
Lysimachia capillipes Hemsl. (Primulaceae), Angelica
sinensis (Oliv.) Diels (Umbelliferae), Kaempferia galanga L.
(Zingiberaceae), Citrus reticulata Blanco (Rutaceae), Chrys-
anthemum morifolium Ramat. (Compositae), Amomum
villosum Lour. (Zingiberaceae), Santalum album L.
(Santalaceae), Eugenia caryophyllata Thunb. (Myrtaceae),
Aucklandia lappa Decne. (Compositae), Lysimachia
foenum-graecum Hance (Primulaceae). These twelve crude
drugs are famous Chinese herbal medicine used for the
treatment of various diseases as well as a tonic medicine for
thousands of years. Among them the chemical properties
and biological activities of Lophatherum gracile Brongn.,
Angelica sinensis (Oliv.) Diels, Gardenia jasminoides Ellis,
Amomum villosum Lour., Citrus reticulata Blanco and
Eugenia caryophyllataThunb. have been widely studied [6].
And the polysaccharide fractions obtained from these
species have been shown to exhibit immunity regulation,
anti-inflammatory, anti-hypoglycemic, anti-bacterial, anti-
tumor, and anti-complementary activities [7-10]. Based on
the above, we designed the method to evaluate whether
ZYQL has the protective effect on immune system.
Cyclophosphamide (Cy), a multifunctional alkylating
agent, is primarily used as an anticancer chemotherapeu-
tic drug in childhood and adult malignancies. Beside a
cytotoxic drug, it also suppresses the immune system
and is referred to as well known immunosuppressive in
case of mammals and birds [11-17]. Studies in mammals
suggest that Cy affects the innate immune system by
causing acute damage to the blood forming tissues in
bone marrow thereby causing transient reduction in cir-
culating PMNs (polymorphonuclear neutrophils) [15]. It
also causes reduction in microsomal enzyme activity,
antioxidant defenses, specific immunity through direct
depletion of lymphoid tissues thus preventing the host
to raise an adequate specific immune response [15,18].
Its modulation in immune reactivity is well known in
mammals and the drug is regarded as a flexible means
to manipulate host responsiveness to malignancies and
infections in a variety of ways [11,13,19,20]. At present,Cy-induced immunosuppressed model is considered as a
well characterized model, which has been extensively
performed in the experiment research.
In the present work, we examined the protective ef-
fects of orally administered processed ZYQL for the im-
mune function. Normal and immunosuppressed mice
induced by Cy (100 mg/kg) were investageted in order
to discover the protective effects of ZYQL on non-
specific and specific immune system. To the best of our
knowledge, there is no any previous studies on the pro-
tective effects of ZYQL for immune function in vivo,
and this is the first report demonstrating the in vivo pro-
tective effects of orally administered ZYQL in normal
healthy mice and immunosuppressed mice treated with
Cy by intraperitoneal injection.
Methods
Drug material
The powder of ZYQL (amber powder) was provided by
Shanxi XinghuaCun Fen Jiu Group Co., Ltd. (Shanxi
Province, China), which was obtained from ZYQL, con-
densed at 50°C by vacuum rotary evaporation. The vou-
cher specimen was deposited at Shihezi University
(Xinjiang, China) and registered under the number
ZYQL 2011050102. This powder was dissolved in steril-
ized distilled water before oral administration to the ex-
perimental animals. All doses given are the gram-weight
of the administered ZYQL powder in sterilized distilled
water.
Experimental animal and design
Male inbred BALB/c mice (18±2 g) were purchased from
the Experimental animal center at Xinjiang Medical Uni-
versity, China. Guidelines for the care and use of animals
were followed and approved by the Ethical Committee
of Shihezi University (Xinjiang, China). The mice were
housed in specific standard laboratory conditions for
one week. The conditions were kept in a temperature-
controlled environment (24±1°C), a relative humidity
(50±5%), and with a regular 12 h light/12 h dark cycle.
All animals were fed with a standard rodent chow diet
and water ad libitum.
Eighty BALB/c mice were randomly divided into eight
groups (n = 10 in each group). Group A served as nor-
mal control and was orally given pure water for fourteen
days, wherein the days 4, 8, 12 intraperitoneally injected
with 10 ml/kg body weight isotonic 0.9% NaCl. Group B
served as immunosuppressed control group and was or-
ally given pure water for fourteen days, wherein the days
4, 8, 12 intraperitoneally intoxicated with 100 mg/kg Cy.
Cy (Endoxan®) was purchased from the affiliated hospital
of Shihezi University, Xinjiang, China. Group C, D, E
were treated with the quantum satis (q.s.) dosages of
ZYQL extract (100, 200 and 400 mg/kg, respectively) for
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peritoneally injected with 10 ml/kg body weight isotonic
0.9% NaCl. Group F, G, H were treated with the
quantum satis (q.s.) dosages of ZYQL extract (100, 200
and 400 mg/kg, respectively) for fourteen days, and
wherein the days 4, 8, 12 intraperitoneally intoxicated
with 100 mg/kg Cy.
On the fifteenth days, the mice were bled, the blood
was collected and centrifuged at 3,000 rpm for 10 min at
4°C, then stored at −80°C until further analyzed. Mice
thymus, spleen and liver were immediately removed and
washed with ice-cold saline, then weighed and stored at
−80°C. The blood and spleen samples were assessed for
their biochemical and antioxidant activities.
Other eighty BALB/c mice were used to detect the
phagocytotic function of mononuclear phagocytic system
with carbon clear up methods, and the experimental de-
sign was the same as the above described.
Biochemical analysis
Serum lysozyme (LSZ), interleukin-6 (IL-6) and interferon-
γ (IFN-γ) levels were measured by ELISA kits obtained
from Sigma-Aldrich Chemicals Co., USA. According to the
manufacturer’s protocol, the observation absorbance of the
reaction was read at 450 nm.
Commercial kits used for determining glutathione perox-
idase (GSH-Px), superoxide dismutase (SOD) and catalase
(CAT) were obtained from Jiancheng Institute of Biotech-
nology (Nanjing, China).
SOD activity in spleen homogenate was assayed as de-
scribed by Beauchamp and Fridovich [21] by measuring
its ability to inhibit the photochemical reduction of nitro
blue tetrazolium (NBT) at 560 nm. Data are expressed
as SOD U/mg protein as compared with the standard.
The measurement of GSH-Px was conducted by the
method of Rotruck [22], which is based on the reaction
between glutathione remaining after the action of GSH-
Px and 5,5′-dithiobis-(2-nitrobenzoic acid) to give a
compound that absorbs light at 412 nm and the enzyme
activity was calculated as μmol/g protein.
CAT activity was determined according to the method of
Aebi [23]. The reaction time interval of the absorbance was
monitored at 240 nm for 1 minute to measure CAT activity
and the data was expressed as U/mg protein.
Carbon clearance methods
On the fifteenth days, all the mice used to detect the
phagocytotic function of mononuclear phagocytic system
with carbon clear up methods were weighed, and then
injected ink diluents (1:5 dilution, 0.1 ml/10 g) in the
caudal vein, in the same time start to count time. Ink
staining was purchased from Beijing Xizhong chemical
plant (Beijing, China). Thirty μl blood was collected in
the time of 2 min (T1) and 10 min (T2) from the venousplexus of the orbital cavity, respectively. Then put the
blood into a sample tube, which contains 3 ml 0.1%
NaCO3. Finally, the OD at 675 nm were determined
by a spectrophotometric microplate reader. The mice
were sacrificed by dislocation cervical vertebra, mice
liver and spleen were obtained and weighed. The carbon
clearance index A was calculated by the following equa-
tion (The manual of health food inspection and evalu-
ation technological specification, 2003 edition):
A ¼ Body weight= Liver þ Spleenð Þ  K1=3
K ¼ logODl−logOD2ð Þ= T 2−Tlð Þ
OD1 : absorbance in 2 min
OD2 : absorbance in 10 min
T 1 : time of 2 min
T 2 : time of 10 min
Statistical analysis
All data were expressed as Means ± Standard Devia-
tions, and analyzed with one-way analysis of variance
(ANOVA) followed by LSD’s test and two-way ANOVA
followed by LSD’s test. Statistical significance was ana-
lyzed by SPSS 13.0 software.
Results
Effect of ZYQL on organ coefficient in normal and
immunosuppressed mice
Organ coefficients including liver, spleen and thymus
coefficients were evaluated in mice. Spleen and thymus
coefficients were significantly decreased in mice with
Cy-treatment (p<0.05 and p<0.01, respectively, Table 1)
compared with the normal group. In contrast, there is
no difference in liver coefficient among all treated
groups. As demonstrated in Table 1, the decrease of thy-
mus coefficient caused by Cy treatment in mice was alle-
viated by ZYQL (100, 200 and 400 mg/kg) (p<0.01,
Table 1). The protective effect against the decrease of
spleen coefficient induced by Cy was observed in mice
with ZYQL (200 and 400 mg/kg) (p<0.05, Table 1).
Dose-effect correlation was observed in ZYQL groups
regarding to the decrease of spleen and thymus coeffi-
cient by Cy-treatment. ZYQL did not enhance the organ
coefficient in the normal mice treated with 100, 200 and
400 mg/kg of ZYQL (Table 1).
Effect of ZYQL on phagocytotic function of mononuclear
phagocytic system
In Table 2, the carbon clearance index of Cy-intoxicated
group was significantly decreased compared with the
normal control group (p<0.01, Table 2). And in the im-
munosuppressed mice group, the carbon clearance were
significantly enhanced after treated with ZYQL (100, 200
and 400 mg/kg) for fourteen days, which compared with
Table 1 Effect of ZYQL on organ coefficient in normal and immunosuppressed mice
Treatment Liver coefficient% Spleen coefficient% Thymus coefficient%
Normal control 4.57±0.38 0.26±0.10 0.16±0.05
Cy(100 mg/kg) 4.80±0.45 0.21±0.06# 0.04±0.01##
ZYQL-A(100 mg/kg) 4.32±0.63 0.29±0.10 0.17±0.05
ZYQL-B(200 mg/kg) 4.39±0.25 0.31±0.06 0.15±0.03
ZYQL-C(400 mg/kg) 4.41±0.48 0.27±0.07 0.15±0.01
ZYQL-A(100 mg/kg)+Cy 4.02±0.21 0.25±0.05 0.12±0.02**
ZYQL-B(200 mg/kg)+Cy 4.28±0.56 0.27±0.03* 0.13±0.03**
ZYQL-C(400 mg/kg)+Cy 4.38±0.40 0.27±0.04* 0.13±0.04**
Data is expressed as the mean±SD (n = 10).
## Significant difference at p<0.01 levels compared with normal control group.
# Significant difference at p<0.05 levels compared with normal control group.
** Significant difference at p<0.01 levels compared with Cy-treated group.
* Significant difference at p<0.05 levels compared with Cy-treated group.
Table 3 Effect of ZYQL on cytokine secretion levels and
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trary, there was no enhancement in the phagocytotic
function in the normal mice treat with 100 and 200 mg/
kg ZYQL compared with the normal control group.
Nevertheless, treated with 400 mg/kg ZYQL alone could
increase the phagocytotic function compared with the
normal control group (p<0.05, Table 2).
Effect of ZYQL on cytokine secretion levels and lysozyme
activity in normal and immunosuppressed mice
In Table 3, the levels of IL-6, IFN-γ and LSZ were sig-
nificantly decreased in the Cy-intoxicated group com-
pared with the normal control group (p<0.01, Table 3).
Compared with the Cy-intoxicated group, ZYQL en-
hanced the production of both IL-6 and IFN-γ in the
serum of immunosuppressed mice (p<0.01, Table 3).
While, there is no significant difference compared with
normal mice. Furthermore, ZYQL (200 and 400 mg/kg)
significantly increased the activity of LSZ in normal miceTable 2 Effect of ZYQL on phagocytotic function of
mononuclear phagocytic system
Treatment Liver+spleena Ab
Normal control 1.65±0.15 3.87±0.74
Cy(100 mg/kg) 1.18±0.14## 3.04±0.65##
ZYQL-A(100 mg/kg) 1.70±0.13 3.99±0.91
ZYQL-B(200 mg/kg) 1.80±0.16 4.23±0.98
ZYQL-C(400 mg/kg) 1.85±0.21 4.35±0.87#
ZYQL-A(100 mg/kg)+Cy 1.43±0.15 3.69±0.46*
ZYQL-B(200 mg/kg)+Cy 1.64±0.18* 3.97±0.58*
ZYQL-C(400 mg/kg)+Cy 1.72±0.16* 4.11±0.62**
Data is expressed as the mean±SD (n = 10).
a g.
b Carbon clearance index.
## Significant difference at p<0.01 levels compared with normal control group.
# Significant difference at p<0.05 levels compared with normal control group.
** Significant difference at p<0.01 levels compared with Cy-treated group.
* Significant difference at p<0.05 levels compared with Cy-treated group.compared with the normal control group (p<0.05-0.01,
Table 3), and similar in case of the immunosuppressed
mice treated with 100, 200 or 400 mg/kg of ZYQL, the
activity of LSZ was significantly increased compared
with Cy only treated group (p<0.05-0.01, Table 3).
Effect of ZYQL on spleen antioxidant enzyme activities in
normal and immunosuppressed mice
Since oxidative stress contributes to the development of
Cy-induced immunosuppression [24], the levels of spleen
antioxidant enzymes SOD, CAT and GSH-Px were mea-
sured. Amounts of SOD, CAT and GSH-Px were signifi-
cantly diminished in the Cy-intoxicated group compared
with the normal control (p<0.01, Table 4). Pretreatment
with 100, 200 and 400 mg/kg of ZYQL significantly
raised the antioxidant enzyme levels as compared with
the Cy-intoxicated group in the immuonsuppressed miceLSZ in normal and immunosuppressed mice
TreatmentΔ IL-6a IFN-γb LSZc
Normal control 74.47±15.12 246.44±32.62 6.31±0.98
Cy(100 mg/kg) 40.56±9.76## 80.96±10.83## 3.87±0.67##
ZYQL-A(100 mg/kg) 81.60±24.82 262.52±55.74 7.03±1.05
ZYQL-B(200 mg/kg) 89.04±15.57 277.61±68.42 7.67±1.12##
ZYQL-C(400 mg/kg) 86.98±11.97 256.81±46.83 7.30±0.91#
ZYQL-A(100 mg/kg)+Cy 80.54±11.37** 185.34±28.81** 4.57±0.85*
ZYQL-B(200 mg/kg)+Cy 101.74±30.72** 231.84±58.32** 8.87±0.76**
ZYQL-C(400 mg/kg)+Cy 79.24±16.66** 230.16±31.63** 7.98±0.98**




## Significant difference at p<0.01 levels compared with normal control group.
# Significant difference at p<0.05 levels compared with normal control group.
** Significant difference at p<0.01 levels compared with Cy-treated group.
* Significant difference at p<0.05 levels compared with Cy-treated group.
Δ Significant difference at p<0.05 (fIFN-γ = 3.692, fLSZ = 3.845) levels compared
between cyclophosphamide- untreated groups and cyclophosphamide-treated
groups (two-way ANOVA followed by LSD’s test).
Table 4 Effect of ZYQL on spleen antioxidant enzyme
activities in normal and immunosuppressd mice
TreatmentΔ GSH-Pxa CATb SODc
Normal control 1029.23±79.08 30.28±2.91 103.07±5.52
Cy(100 mg/kg) 566.53±26.56## 17.23±1.48## 54.66±9.61##
ZYQL-A(100 mg/kg) 1097.86±96.38 33.87±1.05 106.14±14.07
ZYQL-B(200 mg/kg) 1181.81±44.51## 45.02±6.00## 131.75±37.18##
ZYQL-C(400 mg/kg) 1167.57±39.34## 42.96±6.94## 140.00±20.25##
ZYQL-A(100 mg/kg)+Cy 646.71±42.88* 19.85±1.65** 79.16±12.69**
ZYQL-B(200 mg/kg)+Cy 724.57±56.51** 23.57±0.66** 87.46±9.54**
ZYQL-C(400 mg/kg)+Cy 722.08±112.92** 20.24±1.30** 81.66±10.26**




## Significant difference at p<0.01 levels compared with normal control group.
** Significant difference at p<0.01 levels compared with Cy-treated group.
* Significant difference at p<0.05 levels compared with Cy-treated group.
Δ Significant difference at p<0.05 (fCAT = 9.476, fSOD = 2.613) levels compared
between cyclophosphamide-untreated groups and cyclophosphamide-treated
groups (two-way ANOVA followed by LSD’s test).
Gao et al. BMC Complementary and Alternative Medicine 2013, 13:252 Page 5 of 7
http://www.biomedcentral.com/1472-6882/13/252(p<0.05-0.01, Table 4), and similar with the normal mice
treated with 200 or 400 mg/kg of ZYQL compared with
normal control group (p<0.01, Table 4).
Discussion
In the present investigation, we examined the protective
effects of ZYQL on the immune function of normal and
immunosuppressed mice in vivo, which was identified as
an health food for a thousands of years.
Non-specific immunity is an important part in the im-
munity system of the body. Synchronously, it is well
known that macrophages play a key role in the host
defense mechanism and many immunoregulants activate
immune responses primarily by activation of macro-
phages, although direct activation of B cells and other
immune cells also are implicated [25]. So, the phagocy-
totic function of mononuclear phagocytic system is
regarded as the marker to measurement the non-specific
immunity [26]. And the macrophage phagocytotic index
could be reflect the phagocytotic function. In this study,
the phagocytotic function of mononuclear phagocytic
system was detected with carbon clear up methods,
which displayed that ZYQL could increase the carbon
clearance index in the immunosuppressed mice, and
similarly, 400 mg/kg ZYQL exhibited the enhancement
of the carbon clearance index in the normal mice. This
result suggest that ZYQL may enhance the non-specific
immunity by increasing the phagocytic activity of
macrophages.
LSZ is a small, basic, globular mucopolysaccharide
protein consisting of a chain with 129 amino acids
cross-linked by four or five disulphate bridges, which
move actively through the cytoplasm to carry out theirintracellular digestion (i.e., in heterophagy and auto-
phagy). The present work exhibit that ZYQL (100, 200
and 400 mg/kg) treated groups significantly improved
the serum LSZ activity in immunosuppressed mice
(p<0.05-0.01), and ZYQL (200 and 400 mg/kg) treated
groups significantly improved LSZ activity (p<0.05-0.01)
in normal mice. It was shown that LSZ has many func-
tions such as phagocytosis, anti-bacterium, anti-virus
and anti-tumour, and plays an important role in the
clearance of exogenous foreign bodies and endogenous
residues.
Furthermore, cell-mediated immune defense played a
key role in anti-tumor activity and was mediated specif-
ically by T cells and nonspecifically by macrophages and
NK cells. IFN-γ is a potent immunomodulatory cytokine,
it is a member of the interferon family that regulates
anti-proliferative, anti-angiogenic, anti-cancer effects, as
well as, adaptive immune responses [27]. IL-6 is a multi-
functional cytokine, which is produced by both lymphoid
and non-lymphoid cells including macrophages, fibro-
blasts and endothelial cells and involved, in antigen-
specific immune responses and inflammatory reactions
[28]. In the present study, we demonstrated that ZYQL
strongly increased the levels of IFN-γ and IL-6 in the
immunosuppressed mice, while it did not significantly
change these cytokines in normal mice.
In addition, SOD has been reported as one of the most
important enzymes in the enzymatic antioxidant defense
system. It scavenges the superoxide anion to form
hydrogen peroxide and thus diminishing the toxic effect
caused by this radical. ZYQL causes a significant in-
crease in spleen SOD activity in both normal and im-
munosuppressed mice (p<0.01), except in the group of
100 mg/kg ZYQL, and thus reduces reactive free radical
induced oxidative damage to spleen.
CAT is an enzymatic antioxidant widely distributed in
all animal tissues, and the highest activity is found in the
red cells. CAT decomposes hydrogen peroxide and pro-
tects the tissues from highly reactive hydroxyl radicals
[29]. Therefore, reduction in the activity of CAT may re-
sult in a number of deleterious effects due to the assimi-
lation of superoxide radical and hydrogen peroxide. All
doses of ZYQL (100, 200 and 400 mg/kg) are signifi-
cantly increased the level of CAT both in normal and
immunosuppressed mice (p<0.01), except in the group
treated with 100 mg/kg ZYQL only.
GSH-Px is the substrate of glutathione, which could
removes free radical species such as hydrogen peroxide,
superoxide radicals and maintains membrane protein
thiols [30]. And it combined SOD and CAT to formed an
antioxidant defense system of the body. Decreased the
level of GSH-Px exhibits in Cy-treated mice compared the
normal control group (p<0.01). Administration of ZYQL
(100, 200 and 400 mg/kg) significantly increased the level
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(p<0.05-0.01), except in the group treated with 100 mg/kg
ZYQL only.
Moreover, thymus and spleen are the important im-
mune organs of the animal. And their weight can rela-
tively reflect the immune function. Thus, spleen index
and thymus index are considered as the most elementary
and conventional index, which have been generally used
to evaluate the whole immune state of the organism. In
the present work, ZYQL (200 and 400 mg/kg) signifi-
cantly increased thymus index and spleen index in im-
munosuppressed mice (p<0.05 and p<0.01, respectively)
compare with the Cy-intoxicated group, while there is
no significant difference in thymus and spleen indices in
the normal mice treated with ZYQL compare with the
normal control group. This also indicated that ZYQL is
helpful for the immunosuppressed mice.
Conclusions
In conclusion, the present reasearch demonstrated that
ZYQL has the beneficial protective effects on the im-
mune function of normal and immunosuppressed mice
in vivo. Although the exact underlying mechanism of
ZYQL is yet unknown, based on the results presented
above, we can conclude that ZYQL has the protective ef-
fects on the immune function by regulating cytokines
expression, which raised the levels of IL-6 and IFN-γ in
serum. Moreover, the carbon clearance experiment and
the lysozyme activity also suggests that macrophages in-
volved in non-specific immunity were primary activated,
and helper T cell were secondarily affected by ZYQL.
On the other hand, the study showed that ZYQL had
the antioxidant effects in immune system by enhancing
the antioxidant enzyme activity of SOD, CAT and GSH-
Px in vivo. In addition, ZYQL could also increase the
thymus index and the spleen index in the immuno-
suppressed mice. All the above was suggested that
ZYQL could enhance the immunological activity of the
Cy-induced immunosuppressed mice.
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